Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients

Interstitial lung disease (ILD) events have been reported in Japanese non-small-cell lung cancer (NSCLC) patients receiving EGFR tyrosine kinase inhibitors. We investigated proteomic biomarkers for mechanistic insights and improved prediction of ILD. Blood plasma was collected from 43 gefitinib-trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyberg, Fredrik, Ogiwara, Atsushi, Harbron, Chris G., Kawakami, Takao, Nagasaka, Keiko, Takami, Sachiko, Wada, Kazuya, Tu, Hsiao-Kun, Otsuji, Makiko, Kyono, Yutaka, Dobashi, Tae, Komatsu, Yasuhiko, Kihara, Makoto, Akimoto, Shingo, Peers, Ian S., South, Marie C., Higenbottam, Tim, Fukuoka, Masahiro, Nakata, Koichiro, Ohe, Yuichiro, Kudoh, Shoji, Clausen, Ib Groth, Nishimura, Toshihide, Marko-Varga, György, Kato, Harubumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140475/
https://www.ncbi.nlm.nih.gov/pubmed/21799770
http://dx.doi.org/10.1371/journal.pone.0022062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140475/
https://www.ncbi.nlm.nih.gov/pubmed/21799770
http://dx.doi.org/10.1371/journal.pone.0022062

Ejemplares similares